Reviva Pharmaceuticals
RVPH
RVPH
46 hedge funds and large institutions have $5.44M invested in Reviva Pharmaceuticals in 2025 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 8 increasing their positions, 9 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more ownership
Funds ownership: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
less funds holding
Funds holding: →
11% less repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 9
22% less capital invested
Capital invested by funds: $6.95M → $5.44M (-$1.5M)
Holders
46
Holding in Top 10
–
Calls
$2.25M
Puts
$23K
Top Buyers
| 1 | +$2.1M | |
| 2 | +$1.62M | |
| 3 | +$1.42M | |
| 4 |
6CM
683 Capital Management
New York
|
+$779K |
| 5 |
PAP
Persistent Asset Partners
Hong Kong
|
+$374K |
Top Sellers
| 1 | -$487K | |
| 2 | -$206K | |
| 3 | -$191K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$174K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$105K |